Search results
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains | Investing.com
Investing.com· 3 days agoStocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket...
Weight loss jabs not a quick fix to get beach-body ready, warns top NHS doc
Daily Express· 4 days agoPowerful weight loss jabs are not “a quick fix for people trying to get ‘beach body ready’” this...
10 Reasons to Buy Eli Lilly Stock Now
247wallst.com· 3 days agoThe pharmaceutical sector is one that has gone from decades of heavy investment, high growth, and consolidation to a maturing space with a few key...
Everything You Need To Know About DHA
Health via Yahoo News· 6 days agoSupplements If you are looking for a supplement, most omega-3 supplements...DHA might increase the risk of bleeding. DHA also can increase blood glucose...
Is Eli Lilly the Best Pharmaceutical Stock for You? | The Motley Fool
The Motley Fool· 5 days agoEli Lilly (LLY -0.55%) stock has soared 90% over the past year, a huge gain for a pharmaceutical...
Benefits of Sulforaphane: A Compound Found in Broccoli and Other Vegetables
Health.com· 5 days agoSulforaphane is a compound that forms when cruciferous vegetables like broccoli, cabbage, and...
Massive blow for Rishi Sunak as NHS waiting list goes back up to 7.57m
Daily Express· 4 days agoThe NHS waiting list has risen for the first time in seven months, striking a blow to Rishi Sunak’s...
Veru to Present at the American Diabetes Association's 84th Scientific Sessions
Morningstar· 7 days agoThe Phase 2b, multicenter, double-blind, placebo-controlled, randomized, dose-finding clinical trial is designed...
The unique toll of stress and depression on women’s hearts
Anchorage Daily News· 6 days agoDianne Travis-Teague remembers clutching her chest as she navigated the chaos of a crowded hospital...
Arthrosi Presents Positive Phase 2 Data for AR882 at the European Alliance of Associations for...
Tehachapi News· 3 days agoArthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels ...
